A Study of rTMS Personalized Precision Treatment of Post-stroke Depression
Post-stroke Depression
About this trial
This is an interventional treatment trial for Post-stroke Depression focused on measuring Repetitive transcranial magnetic stimulation
Eligibility Criteria
Inclusion Criteria
(1) First-time ischemic stroke with clinical and MRI or CT findings of basal ganglia stroke (ICD-10-CM code 293.83[F06.32]) (3) Right-handedness (4)Clear consciousness (5)Aged 25-75 years with a recent (less than 24 months) ischemic stroke;
Exclusion Criteria
- Aphasia or severe cognitive impairment, severe hearing impairment;
- Contraindications of MRI scan and rTMS treatment such as pacemaker implantation; (3)Depression caused by psychoactive substances and non addictive substances;(4)Prior history of depressive disorders or major trauma within 1 year, severe depression or any other severe mental disorders;
(5)Pregnant or breast-feeding women; (6)Refusal to sign informed consent of this study
Sites / Locations
- Zhujiang hospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
"personalized" rTMS+drug treatment
Traditional rTMS +drug treatment
Received "personalized" rTMS treatment 15 times for 15 days;Take paroxetine for 2 weeks
Received traditional rTMS treatment 15 times for 15 days;Take paroxetine for 2 weeks